Intervention

Peginterferon alfa-2b

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions3

Lead sponsors shown3

Clinical trials

6 shown

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /RibavirinNCT01718301 · 2013-03-10

Zidovudine Levels in HIV Infected Patients Being Treated for HCVNCT00059358 · 2001-09-01

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected PatientsNCT00018031 · 2001-06-01

Safety and Effectiveness of PEG-Intron in HIV-Infected PatientsNCT00005012 · 2000-03-01

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive ChildrenNCT00006325

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionNCT00015652

Common conditions

HIV Infections6 Hepatitis C4 COINFECTION1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)4 Anna Cruceta1 Schering-Plough1

Trial status mix

COMPLETED5

TERMINATED1

Phase mix

PHASE23

PHASE12

NA1

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.